icatibant

a potent bradykinin (B2) receptor antagonist; WIN 65365 is an L-Tic(7) stereoisomer

Also Known As:

D-Arg(Hyp(3)-Thi(5)-D-Tic(7)-Oic(8))BK; D-Arg(Hyp(3)-Thi(5)-L-Tic(7)-Oic(8))BK; Firazyr; HOE 140; HOE-140; HOE140; Hoechst 140; Hoechst-140; JE 049; JE-049; WIN 65365; WIN-65365; icatibant acetate

Pharmalogical Action Categories:

D000894 - Anti-Inflammatory Agents, Non-Steroidal
D065094 - Bradykinin B2 Receptor Antagonists

Amino Acids, Peptides, and Proteins: 1
- Proteins: 496323
  - Intercellular Signaling Peptides and Proteins: 30151
    - Kinins: 2046
      - Bradykinin: 3898
        icatibant: 505
  - Nerve Tissue Proteins: 3
    - Neuropeptides: 6903
      - Bradykinin: 3898
        icatibant: 505
- Peptides: 84029
  - Intercellular Signaling Peptides and Proteins: 30151
    - Kinins: 2046
      - Bradykinin: 3898
        icatibant: 505
  - Neuropeptides: 6903
    - Bradykinin: 3898
      - icatibant: 505
  - Oligopeptides: 527
    - Bradykinin: 3898
      - icatibant: 505
Biological Factors: 2560
- Intercellular Signaling Peptides and Proteins: 30151
  - Kinins: 2046
    - Bradykinin: 3898
      - icatibant: 505
- Inflammation Mediators: 1126
  - Autacoids: 278
    - Kinins: 2046
      - Bradykinin: 3898
        icatibant: 505

M Mansi Selected Research

M Mansi Research Topics

Disease

Drug/Important Bio-Agent (IBA)